We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,564

IP in depth: patentable biotechnology a comparative analysis of key markets
  • Fisher Adams Kelly Callinans
  • Australia, European Union, New Zealand, USA
  • March 31 2015

There is extraordinary complexity and optimization underlying even comparatively 'simple' organisms. These powerful biological products and processes


International News: Focus on International Dispute Resolution
  • McDermott Will & Emery
  • Chile, China, European Union, France, USA
  • December 1 2016

In October 2016, the European Commission launched a public consultation to


Antitrust, Competition and Economic Regulation Quarterly Newsletter - Summer 2017
  • Hogan Lovells
  • European Union, Germany, Hong Kong, United Kingdom, USA
  • June 12 2017

There has been a spate of cases around Europe in which pharmaceutical companies have been accused of pricing at an excessive level. These started


Biosimilars are regulated differently in China
  • Ropes & Gray LLP
  • China, European Union, USA
  • July 22 2015

The Centre for Drug Evaluation (CDE) the technical review body under the China Food and Drug Administration (CFDA) released the Technical


President-elect Trump's potential priorities for insurance regulation
  • Dentons
  • European Union, USA
  • November 22 2016

Apart from a fundamental disagreement between the parties as to whether the Affordable Care Act ("ACA") should be repealed and replaced, insurance


Privacy & Cybersecurity Weekly News Update - Week of October 15
  • Crowell & Moring LLP
  • European Union, USA
  • October 24 2016

St. Joseph Health, a California-based health system, reached an agreement this week to pay $2.1 million to settle alleged HIPAA violations based on


Royalties for revoked patents do not necessarily breach EU competition rules
  • Penningtons Manches LLP
  • European Union, Germany, USA
  • October 25 2016

It is hard to imagine that when Genentech signed a licence agreement in 1992 with Sanofi's predecessor, it could have foreseen the litigation storm


Kartellrechtliche fallstricke im life science-bereich
  • Baker McKenzie
  • European Union, France, USA
  • May 24 2013

Im Wettbewerb gegen Generika ist Vorsicht geboten: Verschiedene Maßnahmen gegen den Markteintritt kostengünstigerer Generika werden


Dispelling the Myriad gene patent harmonization myth
  • Foley & Lardner LLP
  • Australia, Canada, European Union, France, Germany, Japan, USA
  • April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the


Harmonization of Australian patent law will Australia follow the European Biotechnology Directive 9844EC or the U.S. Myriad decision?
  • Houlihan2
  • Australia, European Union, USA
  • July 2 2013

The harmonization of Australia's Intellectual Property laws with overseas jurisdictions is underway. Recent changes brought in by the Intellectual